Colorectal Cancer Clinical Trials in New York

Showing 361-380 of 381 trials

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

NCT00005809

RATIONALE: New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colorectal neoplasia. PURPOSE: Diagnostic study to compare the effectiveness of computerized tomographic colonography with that of standard diagnostic procedures in detecting colorectal neoplasia.

Colorectal Cancer

American College of Radiology Imaging NetworkStarted Jul 2000

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

TERMINATEDPhase 1/2< 1 mile

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

NCT00002796

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Interferon-gamma may interfere with the growth of tumor cells and slow the growth of the tumor. Combining more than one drug with interferon-gamma may kill more tumor cells. This phase I/II trial is studying the side effects and best dose of giving fluorouracil together with phenylbutyrate, indomethacin, and interferon-gamma and to see how well it works in treating patients with stage IV colorectal cancer

Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+7 more

National Cancer Institute (NCI)46 participantsStarted May 1997

New York, New York, United States

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Pain in Cancer Survivors

Study of XL281 in Adults With Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients

Dissemination of Colorectal Cancer Screening to Primary Care Physicians

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Other Conditions in New York